Alpha-1-Antitrypsin from Transgenic Animals (Treatment for Emphysema)

Biology · Biotechnology and Its Applications · NEET

Alpha-1-antitrypsin (α-1-antitrypsin) is a human protein, made by transgenic animals, used to treat emphysema. Scientists put the human gene that codes for this protein into an animal, so the animal makes the medicine cheaply. Memory hook: "Anti-Trypsin, Anti-Emphysema" — A goes with A. This exact pairing was asked in NEET 2024 and NEET 2026.
Alpha-1-Antitrypsin from a Transgenic AnimalHuman gene forα-1-antitrypsininsert geneTransgenic animalcarries foreign genemakesα-1-antitrypsinhuman protein (medicine)Given to patient to treatEMPHYSEMAKey pair:A-1-Antitrypsin = Emphysema
The human gene for alpha-1-antitrypsin is inserted into an animal (making it transgenic). The animal produces the human protein, which is given to patients to treat emphysema. Remember the fixed pair: alpha-1-antitrypsin = emphysema.

Your doubts, answered

Is alpha-1-antitrypsin used for emphysema or cystic fibrosis?

For emphysema. NCERT is very clear: the human protein alpha-1-antitrypsin, made by transgenic animals, is used to treat emphysema. NCERT only says that 'similar attempts are being made' for phenylketonuria (PKU) and cystic fibrosis — those are future goals, not the answer. So the fixed pair to remember is alpha-1-antitrypsin = emphysema.

How do transgenic animals make alpha-1-antitrypsin?

Scientists take the portion of human DNA (the gene) that codes for alpha-1-antitrypsin and put it into an animal. The animal now carries this extra foreign gene, so it becomes a transgenic animal and its body makes the human protein. This is called making a 'biological product'. It is cheaper than making the medicine in a lab.

Is emphysema treated here by gene therapy or by a protein?

By a protein, not by gene therapy. The patient does not receive a new gene. Instead, the transgenic animal makes the protein alpha-1-antitrypsin, and this protein is given to the patient as medicine. Gene therapy (like for ADA deficiency) is a different topic — do not mix them.

What is the difference between Rosie the cow and alpha-1-antitrypsin?

Both come from transgenic animals, but they are different examples. Rosie (1997) was the first transgenic cow, and she produced human protein-enriched MILK (2.4 g/litre). Alpha-1-antitrypsin is a specific human protein made to treat emphysema. NEET can ask either one, so keep them separate in your notes.

Why is alpha-1-antitrypsin made in animals and not in bacteria like insulin?

Insulin is a simple protein, so bacteria (E. coli) can make it. Human proteins like alpha-1-antitrypsin are made in transgenic animals under 'biological products' in NCERT, because such products are often expensive to make and animals can produce them in useful amounts. For NEET, just remember the NCERT example: alpha-1-antitrypsin from transgenic animals treats emphysema.

⚠️ The NEET trap
Alpha-1-antitrypsin is used to treat cystic fibrosis.
Alpha-1-antitrypsin is used to treat emphysema. Cystic fibrosis and PKU are only listed as future 'similar attempts', so they are distractors, not the answer.
🧠 NEET places emphysema, cystic fibrosis, Alzheimer's and rheumatoid arthritis together as options. Only emphysema is the NCERT answer.

Real NEET questions

NEET 2026

The human protein named α-1-antitrypsin, obtained from transgenic animals, is used for the treatment of ______.

A · Emphysema
B · Alzheimer's disease
C · Rheumatoid arthritis
D · Cystic fibrosis
Solution: Transgenic animals are engineered by introducing the human gene that codes for a protein. The protein α-1-antitrypsin so produced is used to treat emphysema (NCERT Ch 10). Alzheimer's, rheumatoid arthritis and cystic fibrosis are distractors — cystic fibrosis is only a future 'similar attempt', not the current use.
NEET 2024

Match List I with List II. List I: A. α-1 antitrypsin B. Cry 1Ab C. Cry 1Ac D. Enzyme replacement therapy List II: I. Cotton bollworm II. ADA deficiency III. Emphysema IV. Corn borer Choose the correct answer.

A · A-III, B-I, C-II, D-IV
B · A-III, B-IV, C-I, D-II
C · A-II, B-IV, C-I, D-III
D · A-II, B-I, C-IV, D-III
Solution: α-1 antitrypsin treats emphysema (III); Cry 1Ab controls corn borer (IV); Cry 1Ac controls cotton bollworm (I); enzyme replacement therapy supplies functional ADA in ADA deficiency (II). This gives A-III, B-IV, C-I, D-II.

Solved Biotechnology and Its Applications NEET PYQs

Try the real previous-year questions from this chapter — each with the answer and a full solution.

See all 29 Biotechnology and Its Applications NEET PYQs ›
Next concept: Transgenic Mice for Vaccine Safety and Toxicity TestingKeep learning — 2 minFeeling ready? Solve the Biotechnology and Its Applications NEET PYQs ›Or practice on your phone — get the free MedicNEET app ›

Frequently asked

What is alpha-1-antitrypsin used for?

It is a human protein used to treat emphysema. In NCERT, it is made by transgenic animals as a biological product.

How is alpha-1-antitrypsin produced in NCERT?

By putting the human gene (DNA) that codes for the protein into an animal. That animal becomes a transgenic animal and makes the protein.

Is alpha-1-antitrypsin the same as Rosie the cow?

No. Rosie (1997) was the first transgenic cow and produced human protein-enriched milk. Alpha-1-antitrypsin is a separate protein example that treats emphysema.

Does alpha-1-antitrypsin cure PKU or cystic fibrosis?

No. NCERT says only that 'similar attempts' are being made for PKU and cystic fibrosis. The confirmed use of alpha-1-antitrypsin is emphysema.

Why is this concept important for NEET?

It is a direct fact that has been asked in NEET 2024 (match-list) and NEET 2026 (direct question). The safe pair to memorise is alpha-1-antitrypsin = emphysema.